For Hospitals, the Road to "Net Zero" Begins with Reprocessing “Single-Use” Devices Net Zero Begins with Extending the Life of “Single-Use” Medical Devices Hospitals that use FDA-cleared, reprocessed medical devices reduce cost, waste, and greenhouse gas emissions. They strengthen our supply chain too. Find out how. LinkedIn Twitter Newsletter For Hospitals,| AMDR | Association of Medical Device Reprocessors
Anti-Reprocessing Interference: Know Your Rights Hospitals use regulated, reprocessed single-use devices (SUDs) to lower costs, reduce waste and emissions, and strengthen the supply chain. But some original equipment manufacturers (OEMs) have undermined these goals by interfering with reprocessing. Research has shown that such interference can be a major barrier to the success of reprocessing| AMDR | Association of Medical Device Reprocessors
Yesterday Court Issued Final Injunction After Jury Finds that Biosense Webster’s Unlawful, Anti-Competitive Practices Forced Hospitals to Purchase More Costly, Wasteful Products [Washington, D.C. — August 28, 2025] — The Association of Medical Device Reprocessors (AMDR) announced that Judge James Selna of the U.S. District Court for the Central District of California has issued a […]| AMDR | Association of Medical Device Reprocessors
June 2025| AMDR | Association of Medical Device Reprocessors
The post ACTION ALERT: Reporting OEM Anti-Reprocessing Interference appeared first on AMDR | Association of Medical Device Reprocessors.| AMDR | Association of Medical Device Reprocessors
Motion filed includes evidence and testimony presented at trial demonstrating the lengths Johnson & Johnson MedTech’s Biosense Webster went to “crush” reprocessor competitors June 20, 2025 FOR IMMEDIATE RELEASE [Note to Editors: The case information discussed in this statement is publicly accessible on PACER and is summarized from the following documents, which AMDR has highlighted The post STATEMENT – Innovative Health Seeks Permanent Injunction Against Johnson & Johnson Medtech’s ...| AMDR | Association of Medical Device Reprocessors
The post ACTION ALERT: Misleading Promotional Tactics by Medtronic Regarding Pulse Oximeter Sensors appeared first on AMDR | Association of Medical Device Reprocessors.| AMDR | Association of Medical Device Reprocessors
[Washington, D.C. and Berlin, Germany / 5 June 2025] Today, Judge James V. Selna of the U.S. District Court for the Central District of California entered judgment in Innovative Health LLC v. Biosense Webster, Inc., tripling the jury’s May 16 award from $147 million to $442 million under federal and California antitrust statutes. The judgment The post Triple Damages — $442M — Awarded to AMDR Member Innovative Health in Case Against Johnson & Johnson’s Biosense Webster Medical Technolo...| AMDR | Association of Medical Device Reprocessors
[Washington, D.C. and Berlin, Germany / 18 May 2025] Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals, providers, patients, and the environment. The jury found that Biosense Webster violated federal and state antitrust laws by withholding clinical The post STATEMENT On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson’s Biosense Webster Medical Te...| AMDR | Association of Medical Device Reprocessors
The “Opt-In” Provision of the EU MDR (Article 17): Undermines EU Law and the Single Market Deprives Hospitals of Sustainable Medical Device Options, and Exacerbates Shortages in the Healthcare Supply Chain The time has come to change it. Summary Health systems are under enormous pressure. Urgently needed amendments to Article 17 of the EU Medical […]| AMDR | Association of Medical Device Reprocessors
